Bausch Health Companies Inc (BHC.TO) — Technical state
As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 54 out of 100 (momentum 87 · quality 50 · valuation 85), as of 2026-11-04.
- Signal: Bullish stack, 200-day still turning — Trades +28.9% vs the 50-day and +44% vs the 200-day average, 9.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 34 sessions ago. Computed from daily closes. (as of 2026-11-03)
- Trend: Bausch Health Companies Inc trades 28.9% above its 50-day and 44.0% above its 200-day moving average. (as of 2026-11-03)
Bausch Health is a diversified specialty pharmaceutical and medical device company operating through five segments: Salix, International, Solta Medical, Diversified and Bausch + Lomb. It develops and sells products across gastroenterology, hepatology, neurology, dermatology, generics, dentistry, over-the-counter care, aesthetic devices and eye health, across many countries.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BHC.TO overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +28.9% vs the 50-day and +44% vs the 200-day average, 9.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 34 sessions ago. Computed from daily closes.
Ranked #50 on today’s Directional Flow — Rising fastest list (scan of 2026-11-03).
The moving-average stack
- vs 20-day+21.1%
- vs 50-day+28.9%
- vs 200-day+44%
- 52-week band9.8% off the high · +87% off the low
- Streak1 consecutive up session
- CrossoverGolden cross 34 sessions ago
- 50-day crossprice crossed up through the 50-day 13 sessions ago
- Stochastic%K 70.3 · %D 78.6
Continue: the BHC.TO chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-03
Quick answers
What is the current Closelooknet signal on BHC.TO?
Bullish stack, 200-day still turning — Trades +28.9% vs the 50-day and +44% vs the 200-day average, 9.8% below the 52-week high and +87% off the 52-week low; a golden cross printed 34 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is BHC.TO above its 50-day and 200-day moving averages?
As of 2026-11-03, Bausch Health Companies Inc trades +28.9% above its 50-day and +44% above its 200-day average, with the 20-day +21.1% away.
How far is BHC.TO from its 52-week high?
9.8% below the 52-week high and 87% above the 52-week low, as of 2026-11-03.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- GALDY GALDERMA GROUP AGindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- ALM.MC Almirall S.A.industry
- IRWD Ironwood Pharmaceuticals Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- UTHR United Therapeutics Corporationindustry
- VETO.PA Vetoquinolindustry
- NBIX Neurocrine Biosciences Incindustry
- XERS Xeris Pharmaceuticals Incindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- AMPH Amphastar Pindustry
- VTRS Viatris Incindustry
- GUD.TO Knight Therapeutics Inc.industry
- ELAN Elanco Animal Healthindustry
- PRGO Perrigo Company PLCindustry
- DHT-UN.TO DRI Healthcare Trustindustry
- FAE.MC Faes Farma SAindustry